These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32937815)

  • 1. Association between
    Lin CH; Yang PJ; Lin SH; Yeh KT; Tsao TC; Chen YE; Lin SH; Yang SF
    Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32937815
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients.
    Yu YY; Chiou HL; Tsao SM; Huang CC; Lin CY; Lee CY; Tsao TC; Yang SF; Huang YW
    Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32365566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
    Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
    Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation.
    Liu TC; Hsieh MJ; Liu MC; Chiang WL; Tsao TC; Yang SF
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients.
    Yang SY; Yang TY; Chen KC; Li YJ; Hsu KH; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Shen CY; Chang GC; Yang PC; Chen CJ
    Clin Cancer Res; 2011 Apr; 17(8):2149-58. PubMed ID: 21300759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of endothelial nitric oxide synthase (
    Huang CY; Hsieh MJ; Wu WJ; Chiang WL; Liu TC; Yang SF; Tsao TC
    J Cancer; 2018; 9(14):2518-2524. PubMed ID: 30026850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism in the epidermal growth factor receptor gene predicts outcome in advanced non-small cell lung cancer patients treated with erlotinib.
    Winther-Larsen A; Nissen PH; Jakobsen KR; Demuth C; Sorensen BS; Meldgaard P
    Lung Cancer; 2015 Nov; 90(2):314-20. PubMed ID: 26386832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR Gene Polymorphism Predicts Improved Outcome in Patients With EGFR Mutation-positive Non-small cell Lung Cancer Treated With Erlotinib.
    Winther-Larsen A; Fynboe Ebert EB; Meldgaard P; Sorensen BS
    Clin Lung Cancer; 2019 May; 20(3):161-166.e1. PubMed ID: 30898568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21.
    Yu JY; Yu SF; Wang SH; Bai H; Zhao J; An TT; Duan JC; Wang J
    Chin J Cancer; 2016 Mar; 35():30. PubMed ID: 27001083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer.
    Tokumo M; Toyooka S; Ichihara S; Ohashi K; Tsukuda K; Ichimura K; Tabata M; Kiura K; Aoe M; Sano Y; Date H; Shimizu N
    Lung Cancer; 2006 Jul; 53(1):117-21. PubMed ID: 16730855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.
    Sasaki H; Endo K; Takada M; Kawahara M; Kitahara N; Tanaka H; Okumura M; Matsumura A; Iuchi K; Kawaguchi T; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Oct; 54(1):103-8. PubMed ID: 16890322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the epidermal growth factor receptor mutation status and differences among molecular subgroups in surgically resected lung microinvasive adenocarcinoma.
    Li M; Li C; Ke L; Zhan M; Cheng M
    Oncol Lett; 2018 Dec; 16(6):7057-7067. PubMed ID: 30546439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
    Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
    Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer.
    Liu TC; Hsieh MJ; Wu WJ; Chou YE; Chiang WL; Yang SF; Su SC; Tsao TC
    Int J Med Sci; 2016; 13(12):929-935. PubMed ID: 27994498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR polymorphism of the kinase domain in Japanese lung cancer.
    Sasaki H; Endo K; Takada M; Kawahara M; Tanaka H; Kitahara N; Matsumura A; Iuchi K; Kawaguchi T; Okuda K; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
    J Surg Res; 2008 Aug; 148(2):260-3. PubMed ID: 18541260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of E-cadherin gene polymorphisms and epidermal growth factor receptor mutation in lung adenocarcinoma.
    Huang CY; Hsieh MJ; Liu TC; Chiang WL; Liu MC; Yang SF; Tsao TC
    Int J Med Sci; 2018; 15(8):765-770. PubMed ID: 30008585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma.
    Guo H; Xing Y; Mu A; Li X; Li T; Bian X; Yang C; Zhang X; Liu Y; Wang X
    Onco Targets Ther; 2016; 9():5257-70. PubMed ID: 27601918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study.
    Esteban E; Majem M; Martinez Aguillo M; Martinez Banaclocha N; Dómine M; Gómez Aldaravi L; Juan O; Cajal R; Gonzalez Arenas MC; Provencio M
    Cancer Epidemiol; 2015 Jun; 39(3):291-7. PubMed ID: 25766256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of metalloproteinase gene polymorphisms and lung cancer.
    Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
    J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum EGFR gene mutation status via second-generation sequencing and clinical features of patients with advanced lung cancer.
    Zhang Z; Zhou S
    Int J Clin Exp Pathol; 2018; 11(7):3551-3558. PubMed ID: 31949733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.